Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The differentiation stage of tumors is a central aspect in the histopathological classification of solid malignancies. The differentiation stage is strongly associated with tumor behavior, and generally an immature tumor is more aggressive than the more differentiated counterpart. While this is common knowledge in surgical pathology, the contribution of differentiation-related gene expression and functions to tumor behavior is often overlooked in the experimental, tumor biological setting. The mechanisms by which tumor cell differentiation stages are perturbed or affected are poorly explored but have recently come into focus with the introduction.of the tumor stem cell concept. While developmental biologists view the differentiation as a unidirectional event, pathologists and tumor biologists have introduced the concept of dedifferentiation to explain phenotypic changes occurring in solid tumors. In this review we discuss the impact of the tumor cell differentiation stage as used in surgical pathology. We further discuss knowledge gained from exploring the molecular basis of the differentiation and dedifferentiation processes in neuroblastoma and breast cancer, two tumor forms where the tumor cell differentiation concept is used in the clinical diagnostic work and where the tumor stem cell theory has been applied.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251 · cited 1×
“According to well-established models, both HIF-1a and HIF-2a subunits become degraded via the proteasomes’ conditions of proper oxygenation (16).”
MethodTumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells
Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.018 · Cited by 1,354 · cited 4×
“Glioma tumor stem/tumorinitiating cells as defined functionally are immature, have neural stem cell properties, and express high HIF-2a protein levels (20).”
BackgroundInfluentialHolmquist-Mengelbier, L., Fredlund, E., Löfstedt, T., Noguera, R., Navarro, S., Nilsson, H., Pietras, A., Vallon-Christersson, J., Borg, Å., Gradin, K., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.026 · Cited by 735
Self-citationHelczynska, K., Larsson, A.-M., Holmquist Mengelbier, L., Bridges, E., Fredlund, E., Borgquist, S., Landberg, G., Påhlman, S., & Jirström, K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1135 · Cited by 136 · cited 2×
“Increased tumor protein levels of HIF-1 and HIF-2, respectively, are also linked to poor patient outcome in breast cancer (reviewed in (26)).”
BackgroundPietras, A., Hansford, L. M., Johnsson, A. S., Bridges, E., Sjölund, J., Gisselsson, D., Rehn, M., Beckman, S., Noguera, R., Navarro, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904606106 · Cited by 135 · cited 1×
“As shown in neuroblastoma, by downregulating HIF-2a in stem cell-like cells, sympathetic neuronal differentiation can be induced (21), and we speculate that HIF-2 inhibition could be a strategy to push immature stem cell-like cells into a more differentiated, bulk-like cell population that can be treated by establishe…”
BackgroundSelf-citationPietras, A., Gisselsson, D., Øra, I., Noguera, R., Beckman, S., Navarro, S., & Påhlman, S. (2008) · The Journal of Pathology · doi:10.1002/path.2304 · Cited by 116 · cited 2×
“However, in clinical samples we found that HIF-2a but not HIF-1a protein was highly expressed in a small subset of neuroblastoma cells close to blood vessels (17-19).”
BackgroundSelf-citationNoguera, R., Fredlund, E., Piqueras, M., Pietras, A., Beckman, S., Navarro, S., & Påhlman, S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0223 · Cited by 78
Self-citation
Cited by
Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis
Fu, Y., Jung, A. W., Torne, R. V., Gonzalez, S., Vöhringer, H., Shmatko, A., Yates, L. R., Jimenez-Linan, M., Moore, L., & Gerstung, M. (2020) · Nature Cancer · doi:10.1038/s43018-020-0085-8 · Cited by 653
Loss of Cell Adhesion Increases Tumorigenic Potential of Polarity Deficient Scribble Mutant Cells
Waghmare, I., & Kango-Singh, M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158081 · Cited by 14
“High grade tumors often have poorly differentiated cells, and altered morphology [50].”
Background
Metadata
- Authors
- Jögi, A., Vaapil, M., Johansson, M., & Påhlman, S.
- Venue
- Upsala Journal of Medical Sciences
- Publisher
- Uppsala Medical Society
- Published
- 2012-02-29
- Volume
- 117
- Issue
- 2
- Pages
- 217-224
- ISSN
- 0300-9734 (ISSN-L)
- 2000-1967
- OpenAlex
- W2150493124
- Cited by
- 206
- References
- 9
- FWCI
- 1.70
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.